Deciphera is a biopharmaceutical company focused on developing new medicines to improve the lives of people with cancer. The company fosters a collaborative culture with opportunities for personal and professional growth.
Develop and execute a strategic territory business plan to support the launch of tirabrutinib for relapsed/refractory primary central nervous system lymphoma patients.
Build strong relationships with hematology/oncology healthcare professionals and key accounts to drive disease education and product readiness.
Communicate clinical data clearly, address barriers to treatment adoption, and collaborate cross-functionally to ensure seamless patient access.